NCT02715583 2022-05-18
C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
Clinical Trials
5 trialsNCT01304485 2019-03-07
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
Phoenix Molecular Imaging
Phase 2 Completed
NCT01144897 2018-10-02
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
University of Iowa
Phase 1 Completed
NCT00924313 2017-07-11
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02169063 2016-08-31
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer
University of Washington
Phase NA Withdrawn